News & Updates

T2DM: SGLT2 inhibitors associated with lower rates of ICU admission and all-cause mortality
T2DM: SGLT2 inhibitors associated with lower rates of ICU admission and all-cause mortality
07 Jun 2023 byNatalia Reoutova

A retrospective observational study of nearly 28,000 patients with type 2 diabetes mellitus (T2DM) in Hong Kong finds that use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is independently associated with lower rates of ICU admission and all-cause mortality across various disease categories.

T2DM: SGLT2 inhibitors associated with lower rates of ICU admission and all-cause mortality
07 Jun 2023
Atopic dermatitis poses heightened risk of venous thromboembolism
Atopic dermatitis poses heightened risk of venous thromboembolism
03 Jun 2023

Adults with atopic dermatitis appear to have an increased risk of venous thromboembolism (VTE), although the risk difference relative to adults without AD is quite small, as reported in a study.

Atopic dermatitis poses heightened risk of venous thromboembolism
03 Jun 2023